Overview

Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)

Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This study will be a multicentre randomized, open-label, phase IIIb study. This study will evaluate two different techniques of sedation: an analgesia based regimen with remifentanil versus a conventional sedation based regimen using propofol in subjects that require mechanical ventilation for at least 2 days in the ICU. The conventional sedation based regimen will consist of propofol combined with an opioid according to routine clinical practice (morphine, fentanyl, sufentanil or other as required) . The analgesia based regimen will consist of remifentanil, with propofol added on if required.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Propofol
Remifentanil